References in periodicals archive ?
Along with the diagnosis, there is an increasing need to evaluate prognostic markers like CD10, BCL2, BCL6 and MUM1 to subcategorize DLBCL into Germinal Centre (GC) type or Activated B Cell (ABC) type as they have different survival rates.
The microRNAs pair with messenger RNA to strike the right balance of BCL2.
Age-associated changes in mouse oocytes during postovulatory in vitro culture: possible role for meiotic kinases and survival factor BCL2.
In difficult cases, fluorescent in situ hybridisation analysis for breakpoints in MYC, BCL2 and BCL6 loci should be undertaken.
Final tissue diagnosis revealed the mass to be an extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) that was CD20 and BCL2 positive (Fig.
It was then carried round the body by the bloodstream, attacking the gene BCL2 which is highly active in lymphoma patients.
Flow cytometry showed a 96% variable size, clonal B cell population expressing CD10, CD11c, CD19, CD20, CD22, CD45, CD52, CD103, CD123, BCL2, and Kappa.
As part of this aim (Aim 1b) we will test whether BCL2 is a target gene of PAX8 and a direct mediator of PAX8 s anti apoptotic role in FTSEC and HGSC.
BCL2, another well-characterized anti-apoptotic gene, can bind BECN1/ATG6 to inhibit BECN1-mediated autophagy and cell death (Luo and Rubinsztein, 2007).
For example, the miR-15a/16-1 cluster targets genes from the apoptotic pathway: BCL2 [21] (B-cell CLL/lymphoma 2) and MCL1 [myeloid cell leukemia sequence 1 (BCL2-related)].